Characteristics of nondepolarizing neuromuscular block: (I) post-junctional block by alpha-bungarotoxin.
The characteristics of neuromuscular block produced by alpha-bungarotoxin, a post-junctionally active polypeptide toxin purified from snake venoms, have been studied in vivo in 12 anaesthetized cats, using the sciatic nerve-tibialis anterior muscle preparation. The onset of the neuromuscular block was slow and without fasciculation. The block was persitently progressive. The time course of the block depended on the dosage. In general, 0.1 mg/kg of alpha-BuTX appeared to approximate the threshold dosage while 0.2 mg/kg completely eliminated the twitch response in 2-5 hours. No recovery was observed in 8-30 hours. Larger doses accelerated the progression of the block. During the block, tetanic contractions and train-of-four twitches did not fade. The post-tetanic twitches were markedly facilitated. The block was antagonized by edrophonium, neostigmine, pyridostigmine, and succinylcholine, but the antagonism was less effective and shorter-lasting than that observed on curare-block, and the block always resumed the projected progression. Attempts were made to explain the observed difference between alpha-BuTX- and dTc-induced neuromuscular blocks by the practically permanent nature of block and the purely post-junctional site of action of alpha-BuTX. It was concluded that a pure post-junctional block is not characterized by fade, which rather might be a pre-junctional effect of some nondepolarizing neuromuscular blocking agents like d-tubocurarine.
D000818:Animals; D002038:Bungarotoxins / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D002415:Cats; D002794:Choline / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004558:Electric Stimulation; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000502:physiology; D003473:Neuromuscular Nondepolarizing Agents; D013390:Succinylcholine / Q000494:pharmacology; D013997:Time Factors
D002038:Bungarotoxins; D002800:Cholinesterase Inhibitors; D003473:Neuromuscular Nondepolarizing Agents; D013390:Succinylcholine; D002794:Choline